Gene Therapy Co. Sangamo Gets Initial OK For $30M DIP
By Alex Wittenberg · June 24, 2026, 6:07 PM EDT
A Delaware bankruptcy judge on Wednesday granted interim approval of a $30 million Chapter 11 financing package for biotechnology company Sangamo Therapeutics Inc., funds that the debtor will use to support a...
To view the full article, register now.